COMMUNIQUÉS West-GlobeNewswire

ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19
18/11/2025
UNIONDALE, NY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today that they will be [...]
Rakovina Therapeutics’ President & CSO to Present and Join Expert Panel at the 9th Annual DDR Inhibitors Summit
18/11/2025
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled [...]
A natural breakthrough in protecting cereals and field crops
18/11/2025
Syngenta and Amoeba SA to develop and commercialize biocontrol solutions for EU and UK Chassieu, France Basel, Switzerland , Nov. 18, 2025 (GLOBE NEWSWIRE) -- Amoebas. These single-celled microorganisms are now at the [...]
Uma inovação natural na proteção de cereais e culturas agrícolas
18/11/2025
Syngenta e Amoéba SA vão desenvolver e comercializar soluções de biocontrolo na UE e no Reino Unido Basileia, Suíça Chassieu, França, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Uma inovação natural na proteção de cereais e [...]
HelixAI launches a new agentic operating system to bring the power of autonomous AI to life sciences
18/11/2025
PRESS RELEASE New operating system enables scientists to move from copilot to autopilot, unifying diverse in silico, wet lab research and scientists to accelerate innovation Partnerships with NVIDIA, AWS and Sapio [...]
Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer
18/11/2025
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, [...]
Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets
18/11/2025
Strategy will combine internal innovation, licensing, and strategic acquisitions to drive sustainable value creation for shareholders Strategic initiative follows positive topline results from pivotal Phase 3 HERIZON- [...]
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s giredestrant becomes the first oral SERD to show superior invasive disease-free survival in early breast cancer
18/11/2025
At interim analysis, giredestrant demonstrated a statistically significant and clinically meaningful benefit versus standard-of-care endocrine monotherapy These unprecedented results support its potential as a new [...]
Apollomics Announces Changes to its Board of Directors and Composition of Committees
18/11/2025
FOSTER CITY, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California-based late-stage clinical biopharmaceutical company, today announced the following [...]
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
18/11/2025
NEW HAVEN, Conn., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced the pricing of an underwritten public offering of 44,000,000 shares of its common stock at an offering price of [...]
Artisan Therapeutics and Tulex Pharmaceuticals Announce Positive Phase 2a Results for ART-501, a Novel Oral Liquid Extended-Release Formulation for Autism Spectrum Disorder
17/11/2025
Artisan and Tulex Report Positive Phase 2a Results for Autism Drug ART-501 SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Artisan Therapeutics, Inc. (“Artisan”) and Tulex Pharmaceuticals (“Tulex”) today announced [...]
Portsmouth Square, Inc. Reports Q1 FY2026 Results; Hotel KPIs Up, Continued Stabilization in San Francisco, and ~$10.1 Million in Cash & Restricted Cash
17/11/2025
Los Angeles, CA, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. (“Portsmouth” or the “Company”) reported results for the three months ended September 30, 2025. Management continues to conclude that the prior [...]
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Komzifti™ (ziftomenib)
17/11/2025
LOUISVILLE, Ky. , Nov. 17, 2025 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Kura Oncology for Komzifti ™ (ziftomenib), indicated for [...]
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
17/11/2025
WAYNE, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory [...]
Eviden-built JUPITER Supercomputer Hits Exascale Milestone According to the TOP500, a First in Europe
17/11/2025
Paris, France – November 17, 2025 – Eviden , the Atos Group product brand leading in advanced computing, announces today the rankings of its 58 Eviden-built systems 1 in the TOP500 and Green500 , official listings of [...]
Crescent Biopharma Announces Grants of Inducement Awards
17/11/2025
WALTHAM, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer [...]
Fennec Pharmaceuticals Announces Closing of Offering of Common Shares
17/11/2025
RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced the closing of its [...]
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference
17/11/2025
WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will [...]
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/11/2025
MALVERN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]

Pages